Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Breast Cancer Research and Treatment
Published October 20, 2026
Age-specific survival after breast conservation versus mastectomy for ductal carcinoma in situ of...
October 21, 2026
Medspoke
Medspoke
The Oncologist
Published October 20, 2026
00:00
--:--
Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer: First U.S. Consensus Highlight...
October 21, 2026
Share
Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer: First U.S. Consensus Highlights on Dosing, Management, and Provider Inertia.
https://www.medspoke.co/channel_journal?id=785&tap_id=16000
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
The Oncologist
Published October 20, 2026
Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma.
October 21, 2026
Why are you reporting this TALK?
